Fondazione Policlinico Universitario Agostino Gemelli IRCCS: Ovarian Neoplasms trials
The registry lists 37 Ovarian Neoplasms studies with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor. 24 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2No phase 33(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HERCULES: Ultrasound-Based Liver Involvement Classification in Ovarian CancerNot yet recruitingNCT07808320
- Machine Learning Algorithms Incorporating Radiomic Ultrasound FeaturesNot yet recruitingNCT07793201
- Predictors of Cognitive Decline and Delirium in Older Women With Ovarian CancerNot yet recruitingNCT07716800
- Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological MalignanciesNot yet recruitingNCT07702721
- Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyNot yet recruitingNCT07645716
- Setting Up ctDNA Analysis on Archived Plasma SamplesRecruitingNCT07546578
- Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinomaRecruitingNCT07540403
- Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian CancerNot yet recruitingNCT07321730
- No-Stoma Policy in Advanced Ovarian Cancer SurgeryRecruitingNCT07213193Not applicable
- Clinical Validation of Sophia Genetics AssayNot yet recruitingNCT07160010
- Proactive Hemodynamic Management During Cytoreductive Surgery and HIPECRecruitingNCT07070973Not applicable
- Prediction of Ovarian Cancer Histotypes and Surgical OutcomeNot yet recruitingNCT07057167
- Short-term Fasting Compared to Free Diet on Ovarian Cancer PatientsRecruitingNCT07039331Not applicable
- Minimally Invasive Interval Debulking Surgery in Advanced Ovarian CancerNot yet recruitingNCT07031908
- Ultrasound Training Program for Gynecologic Cancer Staging in ResidentsNot yet recruitingNCT07028229Not applicable
- A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction ResultsNot yet recruitingNCT06541171
- Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian MassesRecruitingNCT06473766Not applicable
- Mesenteric Infiltration in Ovarian CancerRecruitingNCT06331130
- Spatial Radiogenomics of Ovarian CancerRecruitingNCT06324175
- The Gynecological Cancer Associated Thrombosis (GynCAT) StudyRecruitingNCT06284343
- Patients Derived Organoids in Ovarian CancerRecruitingNCT06085404Not applicable
- SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTSRecruitingNCT06071286Not applicable
- Predicting Outcome of Cytoreduction in Advanced Ovarian CancerRecruitingNCT06017557Not applicable
- Prediction of Germline BRCA 1/2 Genes From Healthy OvariesRecruitingNCT05769517
- An Integrated Genomic Approach to Assess Genetic Risk and Drug SensitivityActive, not recruitingNCT07555639Not applicable
- A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY TrialActive, not recruitingNCT06497270Not applicable
- Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response PredictionActive, not recruitingNCT06065358Not applicable
- Proteogenomic Signatures Analysis In Ovarian CancerActive, not recruitingNCT05953883Not applicable
- Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic EvaluationStatus unknownNCT05763472
- Endocrine Disruptors and Life STILe in Breast Cancer DevelopmentStatus unknownNCT05748353
- Reprab Study: PLD + Trabectedin RechallengeStatus unknownNCT04887961Phase 2
- Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life StudyStatus unknownNCT04617470
- Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoidsStatus unknownNCT04555473
- Efficacy of Letrozole in Recurrent Ovarian CancerTerminatedNCT04421547Phase 3
- NUVOLA TRIAL Open-label Multicentre StudyStatus unknownNCT04261465Phase 2
- SEntine Lymph Node in earLY Ovarian Cancer (SELLY)CompletedNCT03563781Not applicable
- Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype PatientsCompletedNCT02903004Phase 3